Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Developing Novel Treatments for Psychiatric Illnesses: Can Drug Development Tool Qualification Advance CNS Drug Development?

Publication ,  Conference
Brady, L; Davis, M; Pandina, G; Cannon, T; Kolb, H; McPartland, J; Leptak, C; Horner, M; Reasner, D; Lisanby, S; Graham, D; Dage, J; Berman, S
Published in: Neuropsychopharmacology
2021

Duke Scholars

Published In

Neuropsychopharmacology

EISSN

1740-634X

ISSN

0893-133X

Publication Date

2021

Volume

46

Issue

SUPPL 1

Start / End Page

41 / 42

Related Subject Headings

  • Psychiatry
  • 17 Psychology and Cognitive Sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brady, L., Davis, M., Pandina, G., Cannon, T., Kolb, H., McPartland, J., … Berman, S. (2021). Developing Novel Treatments for Psychiatric Illnesses: Can Drug Development Tool Qualification Advance CNS Drug Development? In Neuropsychopharmacology (Vol. 46, pp. 41–42).
Brady, Linda, Michael Davis, Gahan Pandina, Tyrone Cannon, Hartmuth Kolb, James McPartland, Chris Leptak, et al. “Developing Novel Treatments for Psychiatric Illnesses: Can Drug Development Tool Qualification Advance CNS Drug Development?” In Neuropsychopharmacology, 46:41–42, 2021.
Brady L, Davis M, Pandina G, Cannon T, Kolb H, McPartland J, et al. Developing Novel Treatments for Psychiatric Illnesses: Can Drug Development Tool Qualification Advance CNS Drug Development? In: Neuropsychopharmacology. 2021. p. 41–2.
Brady, Linda, et al. “Developing Novel Treatments for Psychiatric Illnesses: Can Drug Development Tool Qualification Advance CNS Drug Development?Neuropsychopharmacology, vol. 46, no. SUPPL 1, 2021, pp. 41–42.
Brady L, Davis M, Pandina G, Cannon T, Kolb H, McPartland J, Leptak C, Horner M, Reasner D, Lisanby S, Graham D, Dage J, Berman S. Developing Novel Treatments for Psychiatric Illnesses: Can Drug Development Tool Qualification Advance CNS Drug Development? Neuropsychopharmacology. 2021. p. 41–42.

Published In

Neuropsychopharmacology

EISSN

1740-634X

ISSN

0893-133X

Publication Date

2021

Volume

46

Issue

SUPPL 1

Start / End Page

41 / 42

Related Subject Headings

  • Psychiatry
  • 17 Psychology and Cognitive Sciences
  • 11 Medical and Health Sciences